Active Stocks

Fri Apr 19 2024 10:25:48

Tata Steel share price
160.50 0.31%

Tata Motors share price
952.25 -1.97%

Infosys share price
1,396.65 -1.68%

ITC share price
424.55 1.34%

NTPC share price
348.35 -0.87%

Business News > Mint Authors > David Wainer

David Wainer

Mint Author

ARTICLES BY DAVID WAINER

Ozempic pens at a Novo Nordisk factory in Denmark.

Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That

3 min read . 18 Mar 2024

Stocks of biotech companies started to bounce back during the second half of last year.

Why That Hot Biotech IPO Could Be a Winner

3 min read . 14 Mar 2024

Oprah is parting ways with WeightWatchers, renamed WW International, announcing last week that she will step down from the board and donate her remaining 1.4% stake.

Oprah’s Breakup With WeightWatchers Shows Turnaround Won’t be Easy

3 min read . 06 Mar 2024

In the ideal world, Vertex’s drug would be so effective that it would simply make opioids obsolete, but it won’t.

Are Alternatives to Addictive Opioids on the Way?

4 min read . 01 Mar 2024

Drug companies have been tinkering with radiotherapy for a long time, but the field hasn’t done well commercially until recently. (Bloomberg)

These drug companies are going nuclear to fight cancer

4 min read . 20 Feb 2024

Drug companies have been tinkering with radiotherapy for a long time, but the field hasn’t done well commercially until recently. (Photo: Bloomberg News)

These drug companies are going nuclear to fight cancer

4 min read . 20 Feb 2024

Eli Lilly has benefited from mass-culture hype that has boosted its stock price beyond what is normal for sector peers.

Why Eli Lilly Deserves to Unseat Tesla Among the Magnificent 7

2 min read . 06 Feb 2024

Combining weight-loss medications with drugs that help preserve muscle is being investigated.

Obesity Drugs Lead to Muscle Loss—Pharma Companies Want to Fix That

3 min read . 22 Jan 2024

President Biden speaking about prescription drug costs at the National Institutes of Health in Bethesda, Md., last month.

Trump and Biden Both Hate Pharma—Investors Shouldn’t

3 min read . 19 Jan 2024

Rising demand for the obesity drug Ozempic is expected to continue boosting its maker, Novo Nordisk, next year.

A Tale of Two Pharmas: Can Obesity Firms Continue Their Outperformance in 2024?

4 min read . 27 Dec 2023

Investing in biotech is tricky because it is a sector of haves and have-nots.

How to Ride the Biotech Roller Coaster

4 min read . 26 Dec 2023

It’s Biotech Stocks’ Time to Shine

It’s Biotech Stocks’ Time to Shine

3 min read . 13 Dec 2023

Gene editing is part of a broader therapeutic revolution that encompasses genetic and cellular medicine. (Image: Pixabay)

Gene editing will change medicine—and maybe health investing too

4 min read . 24 Nov 2023

J&J gets ready to break up with Tylenol

2 min read . 25 Jan 2023

A Covid-19 vaccine turned Moderna into a biotech giant, but the debate over its prospects has continued to rage. (Photo: AP)

Moderna finds life after covid-19

2 min read . 19 Jan 2023

Why biotech is poised for a recovery this year

2 min read . 18 Jan 2023

GE’s spinoff deserves healthy skepticism

3 min read . 08 Jan 2023

Amgen, the world’s biggest biotechnology company by sales, will finance the deal with $8.1 billion in bank loans and the rest through cash it has in the US. Photo: Bloomberg (Bloomberg)

Healthcare deal-making set to surge in 2023

3 min read . 27 Dec 2022

Alzheimer’s is the most common form of dementia, a general term for memory loss and other cognitive abilities serious enough to interfere with daily life. Photo: istock

Alzheimer’s treatment thrills investors as doctors debate effect

3 min read . 06 Dec 2022

Humira is used to treat diseases from rheumatoid arthritis to gut disorders.

World’s top-selling drug going off patent means big bucks for middlemen

2 min read . 05 Dec 2022